The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients

Jan-Erik Damber, Teuvo L J Tammela, Peter Iversen, Per-Anders Abrahamsson, Laurent Boccon-Gibod, Tine Kold Olesen, Egbert van der Meulen, Bo-Eric Persson

    24 Citationer (Scopus)

    Abstract

    To investigate the effects of baseline testosterone on testosterone control and prostate-specific antigen (PSA) suppression using data from a phase III trial (CS21) comparing degarelix and leuprolide in prostate cancer.
    OriginalsprogEngelsk
    TidsskriftUrology
    Vol/bind80
    Udgave nummer1
    Sider (fra-til)174-80
    Antal sider7
    ISSN0090-4295
    DOI
    StatusUdgivet - 2012

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients'. Sammen danner de et unikt fingeraftryk.

    Citationsformater